fluorometholone has been researched along with loteprednol etabonate in 14 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 2 (14.29) | 18.2507 |
2000's | 3 (21.43) | 29.6817 |
2010's | 6 (42.86) | 24.3611 |
2020's | 3 (21.43) | 2.80 |
Authors | Studies |
---|---|
Baru, H; Howes, JF; Neumann, R; Vered, M | 1 |
Bhattacherjee, P; Graff, G; Paterson, CA; Spellman, JM; Yanni, JM | 1 |
Ashmore, ED; Haik, BG; Hill, DA; Morris, WR; Rodriguez-Galindo, C; Wilson, MW | 1 |
Lattanzio, FA; Samudre, SS; Sheppard, JD; Williams, PB | 1 |
Cohen, EJ; Erdurmus, M; Hammersmith, KM; Laibson, PR; Rapuano, CJ; Varssano, D; Yildiz, EH | 1 |
Chiu, TY; Choy, KW; Fan, DS; Lam, DS; Lam, S; Li, WY; Liu, DT; Pang, CP; Qin, Y; Yam, GH | 1 |
Alakuş, MF; Işcan, Y; Oner, V; Taş, M; Türkcü, FM | 1 |
Acharya, NR; Cuddapah, PA; Lietman, TM; Liu, MP; O'Brien, KS; Rose-Nussbaumer, J; Sy, A | 1 |
Feng, MT; Price, FW; Price, MO; Scanameo, A | 1 |
Apsey, DA; Bennion, JL; Caldwell, MC; Schwertner, HA; Stevens, CE; Townley, JR | 1 |
Glass, LRD; Pandit, SA | 1 |
Dvorak, JD; Gill, MS; Murphy, DA; Riaz, KM; Shah, SV | 1 |
Abounoori, M; Mikaniki, E; Mikaniki, M; Peyman, A; Pourazizi, M; Razmjoo, H | 1 |
Bu, F; Huang, T; Shen, Z; Sun, H; Zhang, X | 1 |
1 review(s) available for fluorometholone and loteprednol etabonate
Article | Year |
---|---|
Efficacy and safety of loteprednol etabonate versus fluorometholone in the treatment of patients after corneal refractive surgery: a meta-analysis.
Topics: Cornea; Corneal Opacity; Fluorometholone; Humans; Loteprednol Etabonate; Ocular Hypertension; Refractive Surgical Procedures | 2023 |
3 trial(s) available for fluorometholone and loteprednol etabonate
Article | Year |
---|---|
Topical loteprednol etabonate 0.5 % for treatment of vernal keratoconjunctivitis: efficacy and safety.
Topics: Administration, Topical; Adolescent; Adult; Allergens; Androstadienes; Anti-Allergic Agents; Conjunctivitis, Allergic; Female; Fluorometholone; Glucocorticoids; Humans; Intraocular Pressure; Loteprednol Etabonate; Male; Ophthalmic Solutions; Prednisolone; Prospective Studies; Treatment Outcome; Visual Acuity; Young Adult | 2012 |
Fill levels, cost comparisons, and expulsion force requirements of commonly used topical ophthalmic steroids.
Topics: Costs and Cost Analysis; Double-Blind Method; Fluorometholone; Humans; Loteprednol Etabonate; Ophthalmic Solutions; Prospective Studies; United States | 2022 |
Clinical efficacy of Fluorometholone versus Loteprednol eye drops after photorefractive keratectomy: A triple-blinded randomized controlled trial.
Topics: Cornea; Eye Diseases; Fluorometholone; Humans; Lasers, Excimer; Loteprednol Etabonate; Ophthalmic Solutions; Photorefractive Keratectomy; Retrospective Studies; Treatment Outcome | 2023 |
10 other study(ies) available for fluorometholone and loteprednol etabonate
Article | Year |
---|---|
Loteprednol etabonate: comparison with other steroids in two models of intraocular inflammation.
Topics: Androstadienes; Animals; Anti-Inflammatory Agents; Chronic Disease; Dexamethasone; Disease Models, Animal; Fluorometholone; Intraocular Pressure; Loteprednol Etabonate; Ophthalmic Solutions; Rabbits; Uveitis, Anterior | 1994 |
Pharmacological validation of a feline model of steroid-induced ocular hypertension.
Topics: Administration, Topical; Androstadienes; Animals; Cats; Dexamethasone; Disease Models, Animal; Female; Fluorometholone; Glucocorticoids; Humans; Intraocular Pressure; Loteprednol Etabonate; Ocular Hypertension; Ophthalmic Solutions; Prednisolone; Pregnadienes; Random Allocation; Reproducibility of Results; Tonometry, Ocular | 1999 |
Corneal juvenile xanthogranuloma in a 4-month-old child.
Topics: Androstadienes; Anti-Inflammatory Agents; Biomarkers; Corneal Diseases; Drug Therapy, Combination; Fluorometholone; Humans; Infant; Loteprednol Etabonate; Male; Xanthogranuloma, Juvenile | 2003 |
Comparison of topical steroids for acute anterior uveitis.
Topics: Acute Disease; Administration, Topical; Androstadienes; Animals; Aqueous Humor; Blotting, Western; Conjunctiva; Corneal Stroma; Dexamethasone; Endothelium, Corneal; Eye Proteins; Fibrin; Fluorometholone; Glucocorticoids; Intraocular Pressure; Lipopolysaccharides; Loteprednol Etabonate; Male; Particle Size; Prednisolone; Rabbits; Receptors, Glucocorticoid; Suspensions; Time Factors; Uveitis, Anterior; Vitreous Body | 2004 |
Steroid-induced intraocular pressure elevation or glaucoma after penetrating keratoplasty in patients with keratoconus or Fuchs dystrophy.
Topics: Adolescent; Adult; Aged; Androstadienes; Female; Fluorometholone; Fuchs' Endothelial Dystrophy; Glaucoma; Glucocorticoids; Humans; Intraocular Pressure; Keratoconus; Keratoplasty, Penetrating; Loteprednol Etabonate; Male; Middle Aged; Ocular Hypertension; Prednisolone; Retrospective Studies; Risk Factors; Tonometry, Ocular; Young Adult | 2009 |
A rabbit model of age-dependant ocular hypertensive response to topical corticosteroids.
Topics: Administration, Topical; Age Factors; Androstadienes; Animals; Dexamethasone; Disease Models, Animal; Extracellular Matrix Proteins; Fluorometholone; Glucocorticoids; Intraocular Pressure; Loteprednol Etabonate; Male; Ocular Hypertension; Ophthalmic Solutions; Pregnadienes; Rabbits; Tonometry, Ocular; Trabecular Meshwork | 2012 |
Expert opinion in the management of aqueous Deficient Dry Eye Disease (DED).
Topics: Anti-Allergic Agents; Aqueous Humor; Cyclosporine; Doxycycline; Expert Testimony; Flax; Fluorometholone; Glucocorticoids; Health Care Surveys; Humans; Immunosuppressive Agents; Keratoconjunctivitis Sicca; Lacrimal Apparatus; Loteprednol Etabonate; Practice Patterns, Physicians'; Prosthesis Implantation; Serum; Sjogren's Syndrome | 2015 |
Descemet's Membrane Endothelial Keratoplasty: Risk of Immunologic Rejection Episodes after Discontinuing Topical Corticosteroids.
Topics: Administration, Topical; Adult; Aged; Aged, 80 and over; Cell Count; Corneal Endothelial Cell Loss; Descemet Stripping Endothelial Keratoplasty; Endothelium, Corneal; Female; Fluorometholone; Fuchs' Endothelial Dystrophy; Glucocorticoids; Graft Rejection; Graft Survival; Humans; Longitudinal Studies; Loteprednol Etabonate; Male; Middle Aged; Ophthalmic Solutions; Prednisolone; Prospective Studies; Risk Factors; Withholding Treatment; Young Adult | 2016 |
Dose Uniformity of Topical Corticosteroids: A Simulated Trial of Fluorometholone Acetate 0.1% and Loteprednol Etabonate Gel 0.5.
Topics: Acetates; Anti-Allergic Agents; Chromatography, High Pressure Liquid; Drug Packaging; Fluorometholone; Gels; Humans; Loteprednol Etabonate; Ophthalmic Solutions | 2017 |
Non-glaucoma periocular allergic, atopic, and irritant dermatitis at an academic institution: A retrospective review.
Topics: Academic Medical Centers; Administration, Ophthalmic; Administration, Oral; Adult; Aged; Anti-Allergic Agents; Anti-Bacterial Agents; Dermatitis, Allergic Contact; Dermatitis, Atopic; Dermatitis, Irritant; Drug Therapy, Combination; Eyelid Diseases; Female; Fluorometholone; Glucocorticoids; Humans; Hydrocortisone; Loteprednol Etabonate; Male; Middle Aged; New York; Ophthalmic Solutions; Ophthalmology; Proportional Hazards Models; Referral and Consultation; Retrospective Studies | 2019 |